Table 2

Demographic and clinical characteristics

VariablePresent study
(n=159)
WEAVE/WOVEN
(n=152)
P value
Age, mean±SD59.4±9.561.9±10.5
Female, n (%)39 (24.5%)71 (46.7%)<0.001
Hypertension, n (%)110 (69.2%)140 (92.1%)<0.001
Diabetes mellitus, n (%)53 (33.3%)91 (59.9%)<0.001
Hyperlipidemia, n (%)60 (37.7%)131 (86.2%)<0.001
Smoking, n (%)0.004
 Current smoker45 (28.3%)21 (13.8%)
 Previous smoker43 (27.0%)59 (38.8%)
 Never smoked71 (44.7%)72 (47.4%)
BMI, mean±SD25.66±3.1430.93±7.03
Lesion distribution<0.001
 Anterior circulation63 (39.6%)102 (65.0%)
 Posterior circulation96 (60.4%)55 (35.0%)
Target artery distribution<0.001
 ICA25 (15.7%)40 (25.5%)
 MCA38 (23.9%)62 (39.5%)
 VA48 (30.2%)32 (20.4%)
 BA48 (30.2%)22 (14.0%)
 PCA0 (0.0%)1 (0.6%)
Qualifying ischemic events<0.001
 TIA75 (47.2%)0 (0.0%)
 Ischemic stroke84 (52.8%)152 (100.0%)
Qualifying events on the basis of antiplatelet therapy, n (%)75 (47.2%)
Time to stent from qualifying event (days), median (IQR)20 (9–34)22
Baseline NIHSS, median (IQR)0 (0–2)
Baseline mRS, n (%)<0.001
 096 (60.4%)20 (13.2%)
 148 (30.2%)37 (24.3%)
 215 (9.4%)52 (34.2%)
 30 (0.0%)43 (28.3%)
  • BA, basilar artery; BMI, body mass index; ICA, internal carotid artery; MCA, middle cerebral artery; mRS, modified Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; PCA, posterior cerebral artery; TIA, transient ischemic attack; VA, vertebral artery.